Integrated in-vitro and in-vivo studies to understand your therapeutic product properties

Immuno-monitoring refers to the analysis of immunological parameters including immune cell population phenotyping, cytokine profiling, the assessment of immunogenicity and potential adverse effects such as unintended modulation of the immune system and much more.

This field is crucial in the context of new therapy strategies, such as cell and gene therapy products, including CAR-T cells, therapeutic antibodies, or other immuno-modulating strategies.

CER Groupe is highly specialized in immunology and immuno-monitoring projects and provides in-depth characterization of immunotherapy, vaccine, and ATMP lead candidates. Our bespoke, end-to-end support is appreciated by our partners, as it helps to save time and money by avoiding trial-and-error situations, in particular with humanized mice.

Our expert team helps you design appropriate immuno-monitoring investigation strategies, or to select already qualified methods to accelerate your drug development and integrate it during your pre-clinical in-vitro and in-vivo studies.

Based on a discussion with your product specialist, we help you to select reliable biomarkers, avoiding extensive trial-and-error strategies. We generate high-quality data and manage the project from scratch, all the way up to data analysis.

We also perform assay validation and routine sample processing based on your requirements :

  • Deep expertise with humanized mice
  • Immune cell subsets characterization
  • Immune checkpoint analysis
  • Cytokine profiling
  • Stem/progenitor cells tracking
  • CAR-T cells
  • Therapeutic antibodies
  • Immuno-toxicity

Key figures


> 100 services completed


7 species used for immuno-monitoring studies


> 30 partners

Contact us